लोड हो रहा है...
Beta-blockers in cirrhosis: Evidence-based indications and limitations
Non-selective beta-blockers (NSBBs) are the mainstay of treatment for portal hypertension in the setting of liver cirrhosis. Randomised controlled trials demonstrated their efficacy in preventing initial variceal bleeding and subsequent rebleeding. Recent evidence indicates that NSBBs could prevent...
में बचाया:
| में प्रकाशित: | JHEP Rep |
|---|---|
| मुख्य लेखकों: | , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
Elsevier
2019
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7005550/ https://ncbi.nlm.nih.gov/pubmed/32039404 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jhepr.2019.12.001 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|